<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00007761</url>
  </required_header>
  <id_info>
    <org_study_id>430</org_study_id>
    <nct_id>NCT00007761</nct_id>
  </id_info>
  <brief_title>Does Bipolar Disease Program (BDP) Intervention Improve Long Term Manic and Depressive Symptoms.</brief_title>
  <official_title>CSP #430 - Reducing The Efficacy-Effectiveness Gap In Bipolar Disorder</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>VA Office of Research and Development</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>VA Office of Research and Development</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Based on highly promising preliminary data, it is proposed to conduct a multi-site randomized
      controlled trial of a high-intensity ambulatory treatment program for bipolar disorder
      against standard office-based, physician-centered care. The major characteristics of this
      program are that it emphasizes (1) aggressive guideline-driven pharmacotherapy, (2)
      continuity of care with identified primary mental health nurse clinicians supported by
      psychiatrist back-up, and (3) patient education to improve treatment alliance and illness
      management skills.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Primary Hypothesis: The primary hypotheses are that Bipolar Disease Program (BDP)
      intervention will significantly improve (1) manic and (2) depressive symptom scores, as well
      as Total Treatment Costs as compared to usual care of bipolar patients.

      Secondary Hypothesis: Secondary hypotheses include significant improvement in BDP patients as
      compared to usual bipolar treatment care with respect to functional outcome, quality of life,
      intensity of somatotherapy, patient satisfaction, and provider attitudes.

      Intervention: Usual (psychiatric) Care vs Bipolar Disorder Program

      Primary Outcomes: The primary outcomes are: (1) Manic Symptom Score; (2) Depressive Symptom
      Score; and (3) Total Treatment Costs.

      Study Abstract: Based on highly promising preliminary data, it is proposed to conduct a
      multi-site randomized controlled trial of a high-intensity ambulatory treatment program for
      bipolar disorder against standard office-based, physician-centered care. The major
      characteristics of this program are that it emphasizes (1) aggressive guideline-driven
      pharmacotherapy, (2) continuity of care with identified primary mental health nurse
      clinicians supported by psychiatrist back-up, and (3) patient education to improve treatment
      alliance and illness management skills.

      Patients with bipolar disorder will be randomly assigned to either standard care or the high
      intensity ambulatory program for three years. Outcome variables will cover three distinct
      domains: disease-specific outcome (number, length, and severity of manic and depressive
      episodes), functional outcome (social and occupational role function and subjective quality
      of life), and total treatment costs (direct treatment costs and indirect costs of illness).
      Preliminary data indicate that these domains are related but not redundant. Each of these is
      relevant to patient well-being and to VHA management.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 1997</start_date>
  <primary_completion_date type="Actual">December 2003</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">382</enrollment>
  <condition>Bipolar Disorder</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Bipolar Disorder Program</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Usual (psychiatric) Care</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Bipolar Disorder Program</intervention_name>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Usual (psychiatric) Care</intervention_name>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Patients with bipolar disorder. Index episode of manic, major depression or both requiring
        hospitalization on acute unit. At lease two hospitalizations, three or more months apart
        within the past 5 years.

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mark S Bauer, MD BA</last_name>
    <role>Study Chair</role>
    <affiliation>VA Boston Healthcare System, Brockton Campus</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Southern Arizona VA Health Care System, Tucson</name>
      <address>
        <city>Tucson</city>
        <state>Arizona</state>
        <zip>85723</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>VA Palo Alto Health Care System</name>
      <address>
        <city>Palo Alto</city>
        <state>California</state>
        <zip>94304-1290</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>VA San Diego Healthcare System, San Diego</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92161</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>VA Greater Los Angeles Healthcare System, West LA</name>
      <address>
        <city>West Los Angeles</city>
        <state>California</state>
        <zip>90073</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>VA Eastern Colorado Health Care System, Denver</name>
      <address>
        <city>Denver</city>
        <state>Colorado</state>
        <zip>80220</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>VA Connecticut Health Care System (West Haven)</name>
      <address>
        <city>West Haven</city>
        <state>Connecticut</state>
        <zip>06516</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>VA Medical Center, Augusta</name>
      <address>
        <city>Augusta</city>
        <state>Georgia</state>
        <zip>30904</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Edward Hines, Jr. VA Hospital</name>
      <address>
        <city>Hines</city>
        <state>Illinois</state>
        <zip>60141-5000</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Richard Roudebush VA Medical Center, Indianapolis</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46202-2884</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>VA Boston Healthcare System, Brockton Campus</name>
      <address>
        <city>Brockton</city>
        <state>Massachusetts</state>
        <zip>02301</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>VA Medical Center, Cleveland</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44106</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>James H. Quillen VA Medical Center</name>
      <address>
        <city>Mountain Home</city>
        <state>Tennessee</state>
        <zip>37684</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>VA North Texas Health Care System, Dallas</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75216</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Pirraglia PA, Biswas K, Kilbourne AM, Fenn H, Bauer MS. A prospective study of the impact of comorbid medical disease on bipolar disorder outcomes. J Affect Disord. 2009 Jun;115(3):355-9. doi: 10.1016/j.jad.2008.09.020. Epub 2008 Oct 18.</citation>
    <PMID>18930558</PMID>
  </results_reference>
  <results_reference>
    <citation>Brown GR, McBride L, Bauer MS, Williford WO; Cooperative Studies Program 430 Study Team. Impact of childhood abuse on the course of bipolar disorder: a replication study in U.S. veterans. J Affect Disord. 2005 Dec;89(1-3):57-67. Epub 2005 Oct 4.</citation>
    <PMID>16213029</PMID>
  </results_reference>
  <results_reference>
    <citation>Bauer MS, Williford WO, McBride L, McBride K, Shea NM. Perceived barriers to health care access in a treated population. Int J Psychiatry Med. 2005;35(1):13-26.</citation>
    <PMID>15977942</PMID>
  </results_reference>
  <results_reference>
    <citation>Bauer MS, Altshuler L, Evans DR, Beresford T, Williford WO, Hauger R; VA Cooperative Study #430 Team. Prevalence and distinct correlates of anxiety, substance, and combined comorbidity in a multi-site public sector sample with bipolar disorder. J Affect Disord. 2005 Apr;85(3):301-15.</citation>
    <PMID>15780700</PMID>
  </results_reference>
  <results_reference>
    <citation>Bauer MS, Mitchner L. What is a &quot;mood stabilizer&quot;? An evidence-based response. Am J Psychiatry. 2004 Jan;161(1):3-18. Review.</citation>
    <PMID>14702242</PMID>
  </results_reference>
  <results_reference>
    <citation>Glick HA, McBride L, Bauer MS. A manic-depressive symptom self-report in optical scanable format. Bipolar Disord. 2003 Oct;5(5):366-9.</citation>
    <PMID>14525558</PMID>
  </results_reference>
  <results_reference>
    <citation>Bauer MS. An evidence-based review of psychosocial treatments for bipolar disorder. Psychopharmacol Bull. 2001 Summer;35(3):109-34. Review.</citation>
    <PMID>12397882</PMID>
  </results_reference>
  <results_reference>
    <citation>Bauer MS. A review of quantitative studies of adherence to mental health clinical practice guidelines. Harv Rev Psychiatry. 2002 May-Jun;10(3):138-53. Review.</citation>
    <PMID>12023929</PMID>
  </results_reference>
  <results_reference>
    <citation>Bauer MS. The collaborative practice model for bipolar disorder: design and implementation in a multi-site randomized controlled trial. Bipolar Disord. 2001 Oct;3(5):233-44.</citation>
    <PMID>11903206</PMID>
  </results_reference>
  <results_reference>
    <citation>Bauer MS, Kirk GF, Gavin C, Williford WO. Determinants of functional outcome and healthcare costs in bipolar disorder: a high-intensity follow-up study. J Affect Disord. 2001 Aug;65(3):231-41.</citation>
    <PMID>11511403</PMID>
  </results_reference>
  <results_reference>
    <citation>Vojta C, Kinosian B, Glick H, Altshuler L, Bauer MS. Self-reported quality of life across mood states in bipolar disorder. Compr Psychiatry. 2001 May-Jun;42(3):190-5.</citation>
    <PMID>11349236</PMID>
  </results_reference>
  <results_reference>
    <citation>Bauer MS, Vojta C, Kinosian B, Altshuler L, Glick H. The Internal State Scale: replication of its discriminating abilities in a multisite, public sector sample. Bipolar Disord. 2000 Dec;2(4):340-6.</citation>
    <PMID>11252648</PMID>
  </results_reference>
  <results_reference>
    <citation>Sajatovic M, Biswas K, Kilbourne AK, Fenn H, Williford W, Bauer MS. Factors associated with prospective long-term treatment adherence among individuals with bipolar disorder. Psychiatr Serv. 2008 Jul;59(7):753-9. doi: 10.1176/appi.ps.59.7.753.</citation>
    <PMID>18586992</PMID>
  </results_reference>
  <results_reference>
    <citation>Altshuler L, Tekell J, Biswas K, Kilbourne AM, Evans D, Tang D, Bauer MS. Executive function and employment status among veterans with bipolar disorder. Psychiatr Serv. 2007 Nov;58(11):1441-7.</citation>
    <PMID>17978254</PMID>
  </results_reference>
  <results_reference>
    <citation>Bauer MS, McBride L, Williford WO, Glick H, Kinosian B, Altshuler L, Beresford T, Kilbourne AM, Sajatovic M; Cooperative Studies Program 430 Study Team. Collaborative care for bipolar disorder: Part II. Impact on clinical outcome, function, and costs. Psychiatr Serv. 2006 Jul;57(7):937-45.</citation>
    <PMID>16816277</PMID>
  </results_reference>
  <results_reference>
    <citation>Bauer MS, McBride L, Williford WO, Glick H, Kinosian B, Altshuler L, Beresford T, Kilbourne AM, Sajatovic M; Cooperative Studies Program 430 Study Team. Collaborative care for bipolar disorder: part I. Intervention and implementation in a randomized effectiveness trial. Psychiatr Serv. 2006 Jul;57(7):927-36.</citation>
    <PMID>16816276</PMID>
  </results_reference>
  <results_reference>
    <citation>Sajatovic M, Bauer MS, Kilbourne AM, Vertrees JE, Williford W. Self-reported medication treatment adherence among veterans with bipolar disorder. Psychiatr Serv. 2006 Jan;57(1):56-62.</citation>
    <PMID>16399963</PMID>
  </results_reference>
  <results_reference>
    <citation>Fenn HH, Bauer MS, Altshuler L, Evans DR, Williford WO, Kilbourne AM, Beresford TP, Kirk G, Stedman M, Fiore L; VA Cooperative Study #430 Team. Medical comorbidity and health-related quality of life in bipolar disorder across the adult age span. J Affect Disord. 2005 May;86(1):47-60. Erratum in: J Affect Disord. 2006 Feb;90(2-3):275. Alshuler, Lori [corrected to Altshuler, Lori].</citation>
    <PMID>15820270</PMID>
  </results_reference>
  <results_reference>
    <citation>Kilbourne AM, Bauer MS, Pincus H, Williford WO, Kirk GF, Beresford T; Veterans Administration (VA) Cooperative Study #430 Team. Clinical, psychosocial, and treatment differences in minority patients with bipolar disorder. Bipolar Disord. 2005 Feb;7(1):89-97.</citation>
    <PMID>15654937</PMID>
  </results_reference>
  <results_reference>
    <citation>Glick HA, Kinosian B, McBride L, Williford WO, Bauer MS; CSP #430 Study Team. Clinical nurse specialist care managers' time commitments in a disease-management program for bipolar disorder. Bipolar Disord. 2004 Dec;6(6):452-9.</citation>
    <PMID>15541060</PMID>
  </results_reference>
  <results_reference>
    <citation>Polsky D, Onesirosan P, Bauer MS, Glick HA. Duration of therapy and health care costs of fluoxetine, paroxetine, and sertraline in 6 health plans. J Clin Psychiatry. 2002 Feb;63(2):156-64.</citation>
    <PMID>11874218</PMID>
  </results_reference>
  <results_reference>
    <citation>Bauer MS, Williford WO, Dawson EE, Akiskal HS, Altshuler L, Fye C, Gelenberg A, Glick H, Kinosian B, Sajatovic M. Principles of effectiveness trials and their implementation in VA Cooperative Study #430: 'Reducing the efficacy-effectiveness gap in bipolar disorder'. J Affect Disord. 2001 Dec;67(1-3):61-78.</citation>
    <PMID>11869753</PMID>
  </results_reference>
  <results_reference>
    <citation>Kilbourne AM, Biswas K, Pirraglia PA, Sajatovic M, Williford WO, Bauer MS. Is the collaborative chronic care model effective for patients with bipolar disorder and co-occurring conditions? J Affect Disord. 2009 Jan;112(1-3):256-61. doi: 10.1016/j.jad.2008.04.010. Epub 2008 May 27.</citation>
    <PMID>18504059</PMID>
  </results_reference>
  <verification_date>September 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 29, 2000</study_first_submitted>
  <study_first_submitted_qc>December 30, 2000</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 1, 2001</study_first_posted>
  <last_update_submitted>September 22, 2009</last_update_submitted>
  <last_update_submitted_qc>September 22, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 24, 2009</last_update_posted>
  <responsible_party>
    <name_title>Bauer, Mark - Study Chair</name_title>
    <organization>Department of Veterans Affairs</organization>
  </responsible_party>
  <keyword>Bipolar Disease Program intervention</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bipolar Disorder</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

